6AG-28616-87702
5 vaccinations
9 coded responses
37 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 630 / MO
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Dose 2 — Pfizer-BioNTech
-
2021-04-06
Registered in v-safe
-
2021-04-06
Survey response — day 14, dose 2MedDRA: Disturbance in attention, Dizziness, Taste disorder — Feeling: GoodFree text: I have experienced feelings of lightheadedness. Occasionally have trouble focusing and attending to details. My sense of taste seems off at times. Especially notice taste issues with colas.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — day 21, dose 2MedDRA: Dizziness, Ear pain, Headache, Insomnia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Light-headedness continues. (O2 levels fine.) Not sleeping through night. Headaches. Ear pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-18
Survey response — day 28, dose 2MedDRA: Acne, Dizziness, Fatigue, Headache, Presyncope, Skin disorder, Taste disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Have had feeling in temple like an ice pick stabbing it. Very severe pain.Quite fatigued. Lightheadedness so much that I thought Id lose consciousness. Scalp continues to be covered with acne and sores. Cola still tastes odd.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-25
- 2021-05-02
- 2021-06-20
- 2021-09-19
-
2021-09-25
Dose 3 — Pfizer-BioNTech
- 2021-10-02
-
2021-10-09
Survey response — day 14, dose 3MedDRA: Fatigue, Irritability, Pain in extremity — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fatigue, foot pain, irritability.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Survey response — day 21, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-10-23
Survey response — day 28, dose 3MedDRA: Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: UTIMedDRA releases: 2024-11 · check-in free text available
-
2021-10-23
Report sent to call center — day 28, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-26
- 2021-10-30
-
2021-11-06
Survey response — day 42, dose 3MedDRA: Diarrhoea, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Diarrhea & headaches.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-27
- 2022-03-26
-
2022-04-04
Dose 4 — Moderna
- 2022-04-14
- 2022-04-18
- 2022-04-25
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-07-04
-
2022-09-23
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
-
2022-09-27
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-28
-
2022-09-29
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-30
- 2022-10-07
- 2022-10-14
-
2022-10-21
Survey response — day 28, dose 5MedDRA: Brain fog, Fatigue, Memory impairment — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue. Fuzzy thinking, particularly in the afternoon. (Can't remember names I knew in the morning.) Exhaustion by the end of each working day.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-28
-
2022-11-04
Survey response — day 42, dose 5MedDRA: Eye infection — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Eye InfectionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Report sent to call center — day 42, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-07
- 2022-11-07
- 2022-11-07
- 2022-12-23
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
| 4 | 2022-04-04 | Moderna | No |
| 5 | 2022-09-23 | Pfizer-BioNTech | Flu |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 7 — day 14, dose 2
Symptoms: I have experienced feelings of lightheadedness. Occasionally have trouble focusing and attending to details. My sense of taste seems off at times. Especially notice taste issues with colas.
Release 7 — day 21, dose 2
Symptoms: Light-headedness continues. (O2 levels fine.) Not sleeping through night. Headaches. Ear pain.
Release 7 — day 28, dose 2
Symptoms: Have had feeling in temple like an ice pick stabbing it. Very severe pain.Quite fatigued. Lightheadedness so much that I thought Id lose consciousness. Scalp continues to be covered with acne and sores. Cola still tastes odd.
Release 10 — day 14, dose 3
Symptoms: Fatigue, foot pain, irritability.
Release 10 — day 21, dose 3
Symptoms: Fatigue
Release 10 — day 28, dose 3
Symptoms: UTI
Release 10 — day 42, dose 3
Symptoms: Diarrhea & headaches.
Release 12 — day 28, dose 5
Symptoms: Fatigue. Fuzzy thinking, particularly in the afternoon. (Can't remember names I knew in the morning.) Exhaustion by the end of each working day.
Release 12 — day 42, dose 5
Symptoms: Eye Infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Acne | ✓ | ✓ | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Disturbance in attention | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Ear pain | ✓ | ✓ | ✓ |
| SD | Eye infection | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Presyncope | ✓ | ✓ | ✓ |
| SD | Skin disorder | ✓ | ✓ | ✓ |
| SD | Taste disorder | ✓ | ✓ | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release